Current need in lung cancer Carlos Gil Ferreira
Evolvement of lung cancer treatment Sanjay Popat
Non small cell lung cancer pathogenesis
Non small cell lung cancer overview David Ross Camidge
EGFR Mode of Action
Improving outcomes in lung cancer Marianne Nicolson
HER2 Mode of Action
Lung cancer and afatinib Federico Cappuzzo
Lung Cancer Staging
Lung Cancer Animated Infographic
The Changing Face of Cancer
Lung Cancer Backgrounder
Lung cancer incidence statics in Europe
Angiogenesis in cancer
Tumour growth and angiogenesis
Tumour angiogenesis and apoptosis
Epidermal growth factor (EGF) receptors
Combined EGFR/HER1 and HER2 Inhibition
FGF signaling in tumorigenesis
EGFR dysregulation and inhibition
Pathways in EGFR and HER signaling
Cancer statistics and incidence rates
Resistance to EGFR TKIs
Tumour angiogenesis in lung cancer
A-Z Cancer Glossary
Source for healthcare professionals: www.inoncology.com* BIBF 1120, BIBW 2992 and BI 6727 are investigational compounds. Their safety and efficacy have not yet been fully established.